Jupiter Investment Management’s Zimmer Biomet ZBH Stock Holding History

Jupiter Investment Management’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-14,925	Closed	-$1.5M	–	444
2018 Q4	$1.5M	Buy	+14,925	New	+$1.68M	0.01%	220
2017 Q1	–	Sell	-3,811	Closed	-$381K	–	488
2016 Q4	$381K	Buy	+3,811	New	+$408K	0.01%	269
2015 Q3	–	Sell	-6,077	Closed	-$644K	–	416
2015 Q2	$644K	Buy	+6,077	New	+$672K	0.02%	208
2014 Q2	–	Sell	-12,360	Closed	-$1.13M	–	424
2014 Q1	$1.13M	Buy	+12,360	New	+$1.14M	0.08%	223

Other funds holding ZBH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Jupiter Investment Management's ZBH Position: Q1 2019 in Review

Jupiter Investment Management sold out of Zimmer Biomet (ZBH) in Q1 2019, closing a stake of 14,925 shares — an estimated $1.5M sold.

Jupiter Investment Management first reported a position in ZBH in Q1 2014 and held it in 4 quarters. The position peaked at $1.5M in Q4 2018. 896 funds tracked by Wall St. Rank hold ZBH as of Q1 2019.

Jupiter Investment Management reported no remaining Zimmer Biomet position as of Q1 2019 after selling out during the quarter.
Jupiter Investment Management sold 14,925 Zimmer Biomet shares in Q1 2019, an estimated $1.5M.
Jupiter Investment Management first reported a position in Zimmer Biomet in Q1 2014 and held it in 4 quarters.
Jupiter Investment Management's Zimmer Biomet position peaked at $1.5M in Q4 2018.
896 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2019.

Based on Jupiter Investment Management's 13F filing for Q1 2019, filed 7 May 2019.